Pfizer bets on Arena's promising bowel disease treatment in $6.7 billion deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures muted as oil stays above $100 ahead of earnings
- Oil prices fluctuate on Trump's Russian diesel comments, attacks on Saudi
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) | Delayed: 99.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.98 | 52 Week High | $2.68 | |||
| Open | $0.14 | 52 Week Low | $1.30 | |||
| Day High | $99.98 | P/E | N/A | |||
| Day Low | $99.98 | EPS | $-0.08 | |||
| Volume | 21,430 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.28 | 52 Week Low | $28.25 | |||
| Day High | $28.28 | P/E | 17.14 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 69,200 | |||||
